Sciwind Biosciences Secures US$37 Million Series B Financing

19 Feb, 2021

Sciwind Biosciences Secures US$37 Million Series B Financing
Photo by Med Badr Chemmaoui on Unsplash

– Sciwind biosciences secured US$37m series B financing.
– The financing was led by LYFE Capital and joined by the existing investors, Legend Capital and Haibang Venture Capital.
– Sciwind focuses on research and development of innovative biologics in the therapeutic area of chronic metabolic and immunological diseases and has driven multiple projects into clinical trials.
– Two more IND applications are expected to be filed in 2021 including an oral formulation of a highly active GLP-1 analogue.

Asia Biotechnology Health Care Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: